Funding Forecast Looks Bright

Despite dire predictions that pharmaceutical companies' commercial support of CME would shrink or evaporate entirely, a study conducted by Cutting Edge Information, Research Triangle Park, N. C., shows that funding is on the rise. Released in September 2006, the 165-page study, “Pharmaceutical CME: Measuring Program Effectiveness in the Compliance Environment,” shows that the majority of pharmaceutical companies plan to maintain or increase their levels of CME funding and staffing in 2007. In